The transaction is expected to close in the second quarter of Nichi-Iko’s fiscal year in March 2017. The acquisition also raises the company’s profile as a key player in the domestic and international generics market, particularly in the U.S.
Officials at Nichi-Iko said they do not anticipate any changes to Sagent’s current operations and management team.
More issues about transactions and valuations:
Ministry Door County Medical Center, Hospital Sisters Health System pursue formal partnership
NYU Langone, Winthrop-University Hospital to begin merger talks
Henderson Hospital hiring for hundreds of open positions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
